Breast Cancer Education to Prisoner Women

January 18, 2026 updated by: Fatma Yildirim, Hitit University

Breast Cancer Education for Prisoner Women: Effects on Knowledge and Awareness

this study evaluated the impact of breast cancer education on knowledge and awareness among incarcerated women using a quasi-experimental design.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Breast cancer is the most common cancer among women in the world, accounting for almost a quarter of cancer cases diagnosed among women, with 1.15 million cases diagnosed each year. Breast cancer is common in both developed and developing countries. However, in developing countries, these rates are three times higher and the mortality rate is quite high. Risk factors include age, low socioeconomic level, early menarche, late menopause, family history of breast disease, long-term use of hormone replacement therapy, breastfeeding status and lifestyle habits.

It is reported that breast cancer screening programs such as mammography, breast self-examination (BSE) and clinical breast examination (CMM) have an important role in early diagnosis, increasing the survival rate, reducing the death rate and preventing relapse in breast cancer patients. It has been reported that women who perform regular BSE are more likely to have early stages of the disease, this is because regular BSE gives the woman information about the feel and appearance of the breast. Thus, the woman will be able to detect any changes as early as possible. It is reported that the practice of breast self-examination depends on different factors, including women's knowledge, attitude, socio-demographic and sociocultural factors. Other reasons for low implementation rates, such as lack of time, forgetfulness, and low education level, have also been reported.

Breast cancer is the second leading cause of death after cervical cancer among incarcerated women under the age of 40. 27% of women over the age of 40 had breast cancer, and 18% of these women died. It is of great importance to raise awareness, which is considered one of the main elements of secondary prevention in breast cancer.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
      • Çorum, Turkey (Türkiye)
        • Hitit University
    • Çorum
      • Çorum, Çorum, Turkey (Türkiye), 19600
        • Fatma Yıldırım
      • Çorum, Çorum, Turkey (Türkiye), 19600
        • L type prison

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Volunteering to participate in the study,
  • Being between the ages of 18-65,
  • No history of breast cancer,
  • To know Turkish.

Exclusion Criteria:

  • Those who do not agree to participate in the study,
  • Having a history of breast cancer,
  • Those who do not speak Turkish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Prisoner women receiving breast cancer training
Questionnaires and scales will be administered to the participants as a pre-test. Breast cancer education will be provided in groups and their feedback will be received. Reminder training will be repeated 1 month after the training. The survey and scales will be administered to the participants as a posttest 1 month after the second training.
Other: breast cancer education
Questionnaires and scales will be administered to the participants as a pre-test. Breast cancer education will be provided in groups and their feedback will be received. Reminder training will be repeated 1 month after the training. The survey and scales will be administered to the participants as a posttest 1 month after the second training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Breast Cancer Awareness Scale
Time Frame: first-2. months
The scale is used to measure breast cancer awareness by assessing knowledge of symptoms, appropriate age-related risk, and breast self-examination practices. Higher total scores reflect higher awareness levels.
first-2. months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comprehensive Breast Cancer Knowledge Test
Time Frame: first- 2. months
The scale is used to evaluate breast cancer knowledge and perceptions of treatability through true-false statements, with higher scores reflecting greater knowledge levels.
first- 2. months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hitit University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 24, 2024

Primary Completion (Actual)

August 15, 2024

Study Completion (Actual)

August 15, 2024

Study Registration Dates

First Submitted

May 23, 2024

First Submitted That Met QC Criteria

June 7, 2024

First Posted (Actual)

June 12, 2024

Study Record Updates

Last Update Posted (Actual)

January 21, 2026

Last Update Submitted That Met QC Criteria

January 18, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Hitit_university_1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breast Cancer

Clinical Trials on breast cancer education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe